BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » Neural Stem Cells » Page 5

Top 10 Cities for Stem Cell Searches on Google

By 1 Comment

Do you know the top 10 cities for stem cell searches on Google? It is an interesting question, because Google searches reflect individual interest in the topic. Furthermore, geographical data reflects hotspots where user interest is the greatest.  Together, this data reflects important market dynamics within particular geographical areas.

In the analysis below, Google search data from 2004 to present is presented. This search was executed September 6, 2015, using the Google Trends tool. See the chart and map below to learn the top ten cities where users are searching online for topics about stem cells.  The numbers shown represent search volumes relative to the highest search level identified, which is always 100. [Read more…]

BioInformant Releases “Stem Cell Research Products – Opportunities, Tools, & Technologies” with Market Size, Segments, Trends, & Projections to 2020

By Leave a Comment

February 11, 2016; Washington, DC — BioInformant announces the February 2016 release of its global strategic report, “Stem Cell Research Products, Opportunities, Tools, and Technologies” with market size, segments, trends, and projections to 2020.

The first and only market research firm to specialize in the stem cell industry, BioInformant has more than a decade of historical information on all segments of the stem cell market, by stem cell type. This powerful 175 page global strategic report contains market size, segments, trends, and projections through 2020, as well a social analytics and an end-user survey of nearly 300 stem cell scientists. The “Survey of Stem Cell Scientists” identifies technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide. [Read more…]

Imagine Increasing Revenue from Stem Cell Products and Decreasing Risk

By Leave a Comment

We have helped hundreds of the top companies increase revenue from stem cell products and decrease risk. The key is targeted market intelligence, because it will help you to approach institutional investors for fundraising rounds, guide internal decision-making within your company, and reduce the risk that has traditionally accompanied new product development. Simply put, it will help you make smarter decisions, faster.

Whether or not you can invest in the recently released global strategic report, “Stem Cell Research Products – Opportunities, Tools, and Technologies,” the following is an important introduction to the stem cell research products marketplace, including key trends and future projections. [Read more…]

Do You Know Opportunities for Commercializing Stem Cells, by Stem Cell Type?

By 1 Comment

Commonly investigated stem cell types include embryonic stem cells (ESCs), as well as adult stem cell types that include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs). There are also other less common stem cell types, including dental pulp stem cells (DPSCs), adipose-derived stem cells (ADSCs), and a variety of perinatal stem cell types, including amniotic stem cells, placental stem cells, umbilical cord blood stem cells, and cord tissue stem cells.

Cancer stem cells also exist, giving rise to clonal populations of cells that form tumors or disperse within the body. Each of these stem cell types represents unique opportunities for research product development.

Importantly, literature concerning the biology, characteristics, and applications of stem cells has flourished over the past few decades.

In full-year 2015, there were 25,613 stem cell scientific publications released, and an all-time search returns 259,218 stem cell scientific publications (Pubmed.gov). [Read more…]

Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature

By 1 Comment

Five of the most commonly used stem cell types that are used for research purposes are embryonic stem cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells, and induced pluripotent stem cells.

Therefore, the analysis below considers trends in scientific publication rates for these five stem cell types, over a trailing five-year history. PubMed.gov scientific publication rate data is used for this analysis because of its comprehensive nature.1

PubMed is a service of the U.S. National Library of Medicine and the National Institutes of Health (NIH) that includes over 19 million citations from MEDLINE and other life science journals that date back to the 1950s.2 It is the leading search engine through which to search scientific publications, as NIH researchers are mandated by law to submit their research and most external research is submitted as well, either voluntarily or by mandate.3

TABLE. Comparison of Stem Cell Publication Rates, by Stem Cell Type (Five-Year Historical)
TABLE. Comparison of Stem Cell Publication Rates, by Stem Cell Type (Five-Year Historical)

Year-Over-Year Comparison of Stem Cell Scientific Publications, by Stem Cell Type

Comparison of Stem Cell Research Frequency, by Stem Cell Type

As observed in the graph above, hematopoietic stem cells were the most frequent type of stem cells to be cited in the scientific literature through 2014. Mesenchymal stem cells were the second most common stem cell type through 2014.

In 2015, mesenchymal stem cells surpassed hematopoietic stem cells to become the most common stem cell type to appear within the scientific literature.

This is the first time in history that mesenchymal stem cells substantially outpaced hematopoietic stem cells within the scientific literature.

Additionally, mesenchymal stem cells are the only stem cell type of the five analyzed that had an increase in scientific publications from 2014 to 2015.

All four of the other stem cell types decreased in scientific publication frequency during that period.

Embryonic stem cell research came in third place among the five stem cell types that were analyzed, while neural stem cells and induced pluripotent stem cells both showed lower rates of scientific publications over a trailing five-year period.

Footnotes: 
1Source: Pubmed, http://www.ncbi.nlm.nih.gov/pubmed/. Search Terms: 1) “Embyronic Stem Cell” OR “Embryonic Stem Cells”; 2) “Mesenchymal Stem Cell” OR “Mesenchymal Stem Cells”; 3) “Hematopoietic Stem Cell” OR “Hematopoietic Stem Cells”; 4) “Neural Stem Cell” OR “Neural Stem Cells”; 5) “Induced Pluripotent Stem Cell” OR “Induced Pluripotent Stem Cell” OR “iPSC” OR “iPSCs”. Search Executed: January 24, 2106.
2Ncbi.nlm.nih.gov. 2014. Home – PubMed – NCBI. Available at: http://www.ncbi.nlm.nih.gov/pubmed/. Web . 29 Jan. 2016.
3Science Codex. Available at: http://www.sciencecodex.com/public_access _mandate_made_law. Web. 29 Jan. 2016.

BioInformant's World-Class Clients